Normal high blood pressure or Grade 1 hypertension
Conditions
Interventions
Oral ingestion of the test products containing fermented soba extract (2g per a day
8 weeks)
Oral ingestion of the test products containing fermented soba extract (2g per a day
8 weeks)
Oral ingestion of the placebo not containing fermented soba extract (2g per a day
Sponsors
Laboratory of Cell Applied Technologies, Co
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Males and females aged 30-70 years 2) Individuals who are healthy and are not receiving treatment of disease 3) Individuals who are high normal blood pressure (SBP: 130-140mmHg and/or DBP: 85-90mmHg) and Grade 1 hypertension (SBP: 140-160mmHg and/or DBP: 90-100mmHg) 4) Individuals whose written informed consent has been obtained 5) Individuals judged appropriate for the study by the principal
Exclusion criteria
Exclusion criteria: 1) Individuals who are sensitive to a food containing soba and test product or other foods, and medical products 2) Individuals who are receiving treatment of serious hepatopathy, kidney damage, heart disease and hematological disease 3) Individuals who have a habit of smoking 4) Individuals who had a habit to ingest health-promoting foods, foods for specified health uses, health foods, or supplements in the past 3 months or will ingest those foods during the test period 5) Individuals who participated in other clinical studies in the past three months 6) Individuals who are or are possibly pregnant, or are lactating
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood pressure, pulsation (Week 0, Week 4, Week 8, Week 12) | — |
Countries
Japan
Contacts
Public ContactMasanori Inoue
Laboratory of Cell Applied Technologies, Co Director
Outcome results
None listed